Clinical and Translational Radiation Oncology

Papers
(The median citation count of Clinical and Translational Radiation Oncology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Spatially fractionated radiotherapy (Lattice SFRT) in the palliative treatment of locally advanced bulky unresectable head and neck cancer42
In response to Chuong et al.26
Local relapse patterns after preoperative radiotherapy of limb and trunk wall soft tissue sarcomas: Prognostic role of imaging and pathologic response factors23
HDR brachytherapy versus robotic-based and linac-based stereotactic ablative body radiotherapy in the treatment of liver metastases – A dosimetric comparison study of three radioablative techniques22
Exploring long-term outcomes following CyberKnife robotic radiosurgery for trigeminal neuralgia20
Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center19
Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey16
Fully automatic reconstruction of prostate high-dose-rate brachytherapy interstitial needles using two-phase deep learning-based segmentation and object tracking algorithms13
Postoperative brachytherapy alone for 217 patients with early-stage oral cavity squamous cell carcinoma13
Real-world outcomes of prophylactic cranial irradiation utilization and efficacy for patients with extensive-stage small cell lung cancer treated with consolidative thoracic radiotherapy12
Uterus motion analysis for radiotherapy planning optimization. The innovative contribution of on-board hybrid MR imaging12
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894)11
Adjuvant locoregional radiation therapy in breast cancer patients with pathologic complete response after neoadjuvant chemotherapy: A systematic review and meta-analysis11
Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged ≥ 60 years with Early-stage breast cancer (EPOPE): The rationale 11
In response to Korreman s. et al. Radiation oncologists are, above all, medical doctors10
Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma10
Improved Pathologic response to chemoradiation in MGMT methylated locally advanced rectal cancer9
Postoperative radiotherapy alone is as effective as postoperative chemoradiotherapy in patients with pT4aN0 gingival cancer with negative surgical margins9
Time management: Improving the timing of post-prostatectomy radiotherapy, clinical trials, and knowledge translation9
Identifying predictors of on-table adaptation for pancreas stereotactic body radiotherapy (SBRT)8
A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5 cm based on the estimated incidence of hepatic toxicity8
The cost of elective nodal coverage in prostate cancer: Late quality of life outcomes and dosimetric analysis with 0, 45 or 54 Gy to the pelvis8
Helical tomotherapy for post-mastectomy radiation therapy with or without breast implant: a single institution experience8
Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: Evaluation of predictive factors8
Hypofractionation of radiation dose to the prostate does not necessarily imply a greater risk of acute radiation proctitis8
The efficacy profiles of concurrent chemoradiotherapy with intensity-modulated radiotherapy followed by durvalumab in patients with unresectable stage III non–small cell lung cancer: A multicenter ret7
Prospective Pilot study of Quality of Life in patients with severe late-radiation-toxicity treated by Low hyperbaric-oxigen-therapy7
Reduced-dose WBRT combined with SRS for 1–4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control7
Treatment of an unresectable cardiac angiosarcoma using paclitaxel and image guided radiotherapy: Case report and literature review7
A simple solution to create a custom scalp-sparing helmet to prevent alopecia in patients undergoing total skin electron beam therapy for cutaneous T cell lymphoma7
Radiomics biopsy signature for predicting survival in patients with spinal bone metastases (SBMs)7
Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer7
Incorporating axillary-lateral thoracic vessel juncture dosimetric variables improves model for predicting lymphedema in patients with breast cancer: A validation analysis7
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments7
Cervical body composition on radiotherapy planning computed tomography scans predicts overall survival in glioblastoma patients7
Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how6
The association between diarrhea and serum cytokines in patients with gynecologic cancer treated with surgery and pelvic chemoradiotherapy6
Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan6
Clinical relevance of the radiation dose bath in lower grade glioma, a cross-sectional pilot study on neurocognitive and radiological outcome6
Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy6
Analysis of data to Advance Personalised Therapy with MR-Linac (ADAPT-MRL)6
Machine learning for dose-volume histogram based clinical decision-making support system in radiation therapy plans for brain tumors6
GI factors, potential to predict prostate motion during radiotherapy; a scoping review6
Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish breast cancer group (DBCG) HYPO trial6
18FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancer6
Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trials6
Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease5
Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy5
Individual benefit in heart sparing during DIBH-supported left breast radiotherapy5
Moderately hypofractionated prostate-only versus whole-pelvis radiotherapy for high-risk prostate cancer: A retrospective real-world single-center cohort study5
Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial5
Symptomatic radiation-induced rib fractures after stereotactic body radiotherapy for early-stage non-small cell lung cancer5
Influence of intestinal microbial metabolites on the abscopal effect after radiation therapy combined with immune checkpoint inhibitors5
Application and progress of artificial intelligence in radiation therapy dose prediction5
ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer5
Dosimetric analysis of 17 cardiac Sub-structures, Toxicity, and survival in ultra central lung tumor patients treated with SBRT5
Impact of hyperfractionated re-irradiation on quality of life in patients with recurrent or second primary head and neck cancer, a prospective single institutional study5
Preoperative short-course radiation therapy with PROtons compared to photons in high-risk RECTal cancer (PRORECT): Initial dosimetric experience5
Determining risk and predictors of head and neck cancer treatment-related lymphedema: A clinicopathologic and dosimetric data mining approach using interpretable machine learning and ensemble feature 5
Evaluation of 68Ga-FAPI PET/CT and 18F-FDG PET/CT for the diagnosis of recurrent colorectal cancers5
Comparison of intratumor and local immune response between MV X-ray FLASH and conventional radiotherapies5
Postmastectomy radiation therapy in breast cancer patients with micrometastatic disease in sentinel node dissection: A cohort study and meta-analysis4
Maximum disease diameter is associated with outcomes in stage II follicular lymphoma treated with radiation therapy alone4
Multi-institutional experience of MR-guided stereotactic body radiation therapy for adrenal gland metastases4
Comparison of lifetime attributable risk of post-irradiation secondary cancer of boron neutron capture therapy, proton beam therapy, and X-ray therapy for pediatric and adolescent and young adult pati4
Radiomics of skeletal muscle helps to predict gastrointestinal toxicity in locally advanced rectal cancer patients receiving neoadjuvant chemoradiotherapy4
Clinical implementation of RTT-only CBCT-guided online adaptive focal radiotherapy for bladder cancer4
A first evaluation of the efficacy of minibeam radiation therapy combined with an immune check point inhibitor in a model of glioma-bearing rats4
Value of 18F-fluorocholine PET/CT in predicting response to radical radiotherapy in patients with localized prostate cancer4
Letter to the Editor4
Targeting K-Ras-mediated DNA damage response in radiation oncology: Current status, challenges and future perspectives4
Stereotactic body radiation therapy to postpone systemic therapy escalation for castration-resistant prostate cancer: A multicenter retrospective analysis4
Impact of reduced margin pelvic radiotherapy on gastrointestinal toxicity and outcome in gynecological cancer4
Is single fraction the future of stereotactic body radiation therapy (SBRT)? A critical appraisal of the current literature4
Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy4
C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect4
Patterns of failure for recurrent head and neck squamous cell carcinoma treated with salvage surgery and postoperative IMRT reirradiation4
Effectiveness, toxicity and impact on quality of life of high-dose-rate brachytherapy delivered in two fractions as monotherapy in patients with prostate cancer4
Ex vivo radiation sensitivity assessment for individual head and neck cancer patients using deep learning-based automated nuclei and DNA damage foci detection4
A time-resolved clonogenic assay for improved cell survival and RBE measurements4
Stabilised Hyaluronic Acid (sHA) gel as a novel marker for breast cancer tumour bed cavity: Surgical feasibility4
Bridging the care gap: patients’ needs and experiences regarding shared decision-making in radiotherapy4
A knowledge graph representation of baseline characteristics for the Dutch proton therapy research registry4
Dynamic changes in cardiac biomarkers in radiotherapy for oesophageal cancer and their correlations with cardiac radiation dosimetry4
Enhancing radiotherapy outcomes in rectal cancer: A systematic review of targeting hypoxia-induced radioresistance4
All for one: Collaboration between dermatologist, radiation oncologist and radiologist in the clinical management of “difficult to treat” non melanoma skin cancer4
Inhibition of OXPHOS induces metabolic rewiring and reduces hypoxia in murine tumor models4
PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer4
Hypoxia in relationship to tumor volume using hypoxia PET-imaging in head & neck cancer – A scoping review4
Radiotherapy induces an increase in serum antioxidant capacity reflecting tumor response4
The current status of brachytherapy in Europe − A GEC-ESTRO Brachy-HERO survey4
ESTRO guidelines for developing questionnaires in survey-based radiation oncology research4
Extramedullary hematopoiesis causing spinal cord compression in polycythemia vera: A case report and literature review4
Validity test of small cell lung cancer (SCLC) graded prognostic assessment and proposal of a new index for patients with brain metastases from SCLC4
Determining the gross tumor volume for hepatocellular carcinoma radiotherapy based on multi-phase contrast-enhanced magnetic resonance imaging4
Radiation response assessment of organoids derived from patients with pancreatic cancer4
Stereotactic body radiation therapy for adrenal gland metastases: A multi-institutional outcome analysis4
Early radiologic and metabolic tumour response assessment during combined chemo-radiotherapy for locally advanced NSCLC4
Anatomical and dosimetric variations during volumetric modulated arc therapy in patients with locally advanced nasopharyngeal carcinoma after induction therapy: Implications for adaptive radiation the3
Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer3
Clinical implementation of standardized neurocognitive assessment before and after radiation to the brain3
A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence3
Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5 T MR-linear accelerator hybrid system: A prospective R-IDEAL stage 2a imaging biomarker characterizat3
Phase I/II trial of concurrent extracranial palliative radiation therapy with Dabrafenib and Trametinib in metastatic BRAF V600E/K mutation-positive cutaneous Melanoma3
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)3
Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study3
Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinoma3
Do We Have a Winner? Advocating for SBRT in HCC Management3
Brachytherapy boost in anal canal cancer – A GEC ESTRO PDR task force meta-analysis3
Prostate cancer radiotherapy and incidental testicular irradiation: Impact on gonadal function3
An impact model to understand and improve work-life balance in early-career researchers in radiation oncology3
PTCOG international survey of practice patterns and trends in utilization of proton therapy for breast cancer3
Stereotactic body radiation therapy in patients with centrally located hepatocellular carcinoma: A retrospective, single-arm, multi-center study3
First treatments for Lattice stereotactic body radiation therapy using magnetic resonance image guided radiation therapy3
A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer3
Stable use of radiotherapy in lymphoma patients over time – A comprehensive national overview of radiotherapy use in Sweden with focus on older patients3
Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial3
Scalp angiosarcoma treated with linear accelerator-based boron neutron capture therapy: A report of two patients3
Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study3
Nodal recurrence mapping and clinical target volumes after resection of intrahepatic cholangiocarcinoma or combined hepatocellular-cholangiocarcinoma3
4D-MRI assisted stereotactic body radiation therapy for unresectable colorectal cancer liver metastases3
MR-guided stereotactic radiation therapy for head and neck cancers3
External validation of Cardiac disease, Hypertension, and Logarithmic Left anterior descending coronary artery radiation dose (CHyLL) for predicting major adverse cardiac events after lung cancer radi3
Contact X-ray Brachytherapy as a sole treatment in selected patients with early rectal cancer – Multi-centre study3
Utility of interim apparent diffusion coefficient value in predicting treatment response among patients with locally advanced cervical cancer treated with radiotherapy3
ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy3
Blood-brain barrier permeability following conventional photon radiotherapy – A systematic review and meta-analysis of clinical and preclinical studies3
Single-institution analysis of the prevalence, indications and outcomes of end-of-life radiotherapy3
Hypofractionated radiotherapy combined with targeted therapy or immunotherapy: Dutch survey on current practice, knowledge and challenges3
Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trial3
Rate of pachymeningeal failure following adjuvant WBRT vs SRS in patients with brain metastases3
Predictive clinical and dosimetric parameters for risk of relapse in early-stage non-small cell lung cancer treated by SBRT: A large single institution experience3
Redefining postmastectomy radiation contouring in the era of immediate breast reconstruction: An accurate assessment of local recurrence risk3
Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial3
Neoadjuvant chemoradiotherapy up-regulates PD-L1 in radioresistant colorectal cancer3
Evaluating the radiosensitivity of the oral microbiome to predict radiation-induced mucositis in head and neck cancer patients: A prospective trial2
Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review2
Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac2
A retrospective review of the long-term outcomes of online adaptive radiation therapy and conventional radiation therapy for muscle invasive bladder cancer2
Prognostic utility of pretreatment neutrophil-lymphocyte ratio in survival outcomes in localized non-small cell lung cancer patients treated with stereotactic body radiotherapy: Selection of an ideal 2
A single-institution phase I feasibility study of dose-escalated IMRT for non-operative locally advanced esophageal carcinoma2
A total inverse planning paradigm: Prospective clinical trial evaluating the performance of a novel MR-based 3D-printed head immobilization device2
Overall survival nomogram for patients with spinal bone metastases (SBM)2
Construction and validation of a prognostic nine-gene signature associated with radiosensitivity in head and neck squamous cell carcinoma2
Clinical outcomes of pelvic bone marrow sparing radiotherapy for cervical cancer: A systematic review and meta-analysis of randomised controlled trials2
Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicity2
Weekly ultra-hypofractionated radiotherapy in localised prostate cancer2
Personalizing dental screening and prevention protocols in dentulous patients with oropharyngeal cancer undergoing radiotherapy: A retrospective cohort study2
Stereotactic ablative radiotherapy for treating primary head and neck cancer and locoregional recurrence: A comprehensive review of the literature2
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol2
Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer2
Cleaning radiotherapy contours for radiomics studies, is it worth it? A head and neck cancer study2
Total skin electron beam therapy for cutaneous T-cell lymphomas in the Netherlands: A retrospective analysis of treatment outcomes and selection for high or low dose schedule2
Association between radiotherapy protocol variations and outcome in the CONVERT trial2
Re-irradiation to the prostate using stereotactic body radiotherapy (SBRT) after initial definitive radiotherapy – A systematic review and meta-analysis of recent trials2
Considerations regarding carotid artery dose in radiotherapy of the cervical spine2
Empirical planning target volume modeling for high precision MRI guided intracranial radiotherapy2
Systemic therapy escalation after stereotactic body radiation therapy for oligometastatic hormone-sensitive prostate cancer2
The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation2
A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group2
MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study2
Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer2
Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature2
Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at risk2
The ROCOCO performance scoring system translates dosimetric differences into clinically relevant endpoints: Comparing IMPT to VMAT in an example pilocytic astrocytoma dataset2
Effects of proton therapy on regional [18F]FDG uptake in non-tumor brain regions of patients treated for head and neck cancer2
Exclusion of non-Involved uterus from the target volume (EXIT-trial): An individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques followed by comp2
A pilot study of same-day MRI-only simulation and treatment with MR-guided adaptive palliative radiotherapy (MAP-RT)2
MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study2
MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study2
Artificial intelligence to predict outcomes of head and neck radiotherapy2
Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma2
Avoiding prostate bed radiation for the PSMA-PET detected nodal recurrence patient post prostatectomy2
New curative approach using embolization followed by moderate-dose radiotherapy after surgical failure for large right heart metastasis2
Clinical evaluation of a deep learning CBCT auto-segmentation software for prostate adaptive radiation therapy2
Regional nodal irradiation (RNI) in breast cancer patients with residual isolated tumor cells or micrometastatic nodal disease after neoadjuvant chemotherapy2
A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic2
Long-term outcomes of an esophagus-preserving chemoradiotherapy strategy for patients with endoscopically unresectable stage I thoracic esophageal squamous cell carcinoma2
Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre2
An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases2
Long-term outcomes of more than a decade treating patients with stereotactic body radiation therapy for hepatocellular carcinoma2
Acute toxicity patterns and their management after moderate and ultra- hypofractionated radiotherapy for prostate cancer: A prospective cohort study2
Feasibility of biology-guided radiotherapy for metastatic renal cell carcinoma driven by PSMA PET imaging2
Nomogram for radiation-induced lymphopenia in patients receiving intensity-modulated radiotherapy based-chemoradiation therapy for newly diagnosed glioblastoma: A multi-institutional study2
Comment on Hunt et al, “Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer”2
Pelvic insufficiency fractures after intensity modulated radiation therapy combined with chemotherapy for cervix carcinoma: Incidence and impact of bone mineral density2
The impact of rectal spacers in MR-guided adaptive radiotherapy2
Lung cancer epidermal growth factor receptor mutations and radiotherapy response: A multicentre clinical study2
Total dose, fraction dose and respiratory motion management impact adrenal SBRT outcome2
Prospective evaluation of intensity-modulated radiotherapy toxicity in extremity soft tissue sarcomas patients: A role for irradiated healthy soft tissue volume?2
Metastases-directed radiotherapy in castration resistant oligo metastatic prostate cancer: A multicentric retrospective study from the French group COLib2
Organ-sparing techniques and dose-volume constrains used in breast cancer radiation therapy – Results from European and Latin American surveys2
Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study)2
Comment on Hunt et al., “Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer”2
Elective pelvic nodal irradiation in elderly men treated with hypofractionated radiotherapy2
#radonc: Growth of the global radiation oncology Twitter network2
Second malignancies in patients with Hodgkin’s Lymphoma: Half a century of experience2
Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases2
10-Year oncological outcome report after second conservative treatment for ipsilateral breast tumor event2
MRI-guided adaptive radiotherapy for prostate cancer: When do we need to account for intra-fraction motion?1
Feasibility of low-dose radiotherapy for patients with stage I/II extranodal NK-/T-cell lymphoma, nasal type achieving complete response after l-asparaginase-containing chemotherapy1
The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change?1
Factors associated with complex oral treatment device usage in patients with head and neck cancer1
Dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring of liver tumors using a gimbal-mounted linac: A multi-institutional phase II study1
The oxygen puzzle in FLASH radiotherapy: A comprehensive review and experimental outlook1
Immunological responses to brain metastasis stereotactic radiosurgery in patient-matched longitudinal blood and tumour samples1
Stereotactic body radiation therapy in primary liver tumor: Local control, outcomes and toxicities1
Cardiac radioablation in the treatment of ventricular tachycardia1
Personalized neck irradiation guided by sentinel lymph node biopsy in patients with squamous cell carcinoma of the oropharynx, larynx or hypopharynx with a clinically negative neck: (Chemo)radiotherap1
Cardiorespiratory-gated cardiac proton radiotherapy using a novel ultrasound guidance system1
The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG survey1
The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer1
PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma1
Current practices and perspectives on the integration of contrast agents in MRI-guided radiation therapy clinical practice: A worldwide survey1
Clinical management of oligometastatic cancer: Applying multidisciplinary tumor board recommendations in practice1
Real-world utilisation of brachytherapy boost and patient-reported functional outcomes in men who had external beam radiation therapy for prostate cancer in Australia1
Postoperative SBRT in the treatment of early-stage oropharyngeal and oral cavity cancers with high-risk margins: A dosimetric comparison of volumetric modulated arc therapy with or without non-coplana1
Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation1
Morphological changes after cranial fractionated photon radiotherapy: Localized loss of white matter and grey matter volume with increasing dose1
GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer1
Normal tissue complication probability modeling for late rectal bleeding after conventional or hypofractionated radiotherapy for prostate cancer1
Stereotactic lung reirradiation for local relapse: A case series1
Clinical outcomes of esophageal squamous cell carcinoma in patients with cirrhosis1
Complications leading to hospitalisation 12 months after brachytherapy or high-intensity focused ultrasound for localized prostate cancer: French national from the PMSI-MCO data, 2019 and 20201
The overall survival impact of prophylactic cranial irradiation in limited-stage small-cell lung cancer: A systematic review and meta-analysis1
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study1
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer1
Planned organ preservation for elderly patients with rectal cancer using short course radiotherapy and a contact brachytherapy boost-an International multi-institution analysis1
Nomogram to predict risk of early mortality following definitive or adjuvant radiation and systemic therapy for head and neck cancer1
Treating oligodendroglioma – An analysis of a homogeneous 1p/19q-codeleted and isocitrate dehydrogenase-mutant patient cohort1
Quantifying radiation-induced breast fibrosis by shear-wave elastography in patients with breast cancer: A 12-months-follow-up data of a prospective study1
CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer1
Associations between patient-reported outcomes and radiation dose in patients treated with radiation therapy for primary brain tumours1
Refractory ventricular tachycardia treated by a second session of stereotactic arrhythmia radioablation1
A real-world analysis of stereotactic body radiotherapy combined with immunotherapy in advanced or recurrent non-small cell lung cancer (NSCLC): A single-center experience1
Does brachytherapy boost improve survival outcomes in Gleason Grade Group 5 patients treated with external beam radiotherapy and androgen deprivation therapy? A systematic review and meta-analysis1
The role of image-guided radiotherapy in prostate cancer: A systematic review and meta-analysis1
CT-guided online adaptive stereotactic body radiotherapy for pancreas ductal adenocarcinoma: Dosimetric and initial clinical experience1
Is postoperative radiotherapy effective in patients with completely resected pathologic stage IIIA(N2) non-small cell lung cancer? High-risk populations should consider it1
Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospecti1
The prognostic utility of IGF-1 in hepatocellular carcinoma treated with stereotactic body radiotherapy1
Study protocol: PreOperative Brain Irradiation in Glioblastoma (POBIG) – A phase I trial1
Adaptive radiotherapy for breast cancer1
Treatment time and learning curve analysis of 1.5 T MR-Linac workflows led by radiation oncologists or therapists1
Individual elective lymph node irradiation for the reduction of complications in head and neck cancer patients (iNode): A phase-I feasibility trial protocol1
“Radiotherapy for thymic epithelial tumors: What is the optimal dose? A systematic review.”1
Reply to comments on “Refractory ventricular tachycardia treated by a second session of stereotactic arrhythmia radioablation”1
Erectile function preservation after salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: Five-year results of the SAKK 09/10 randomized phase 3 trial1
Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general population1
Treatment planning for MR-guided SBRT of pancreatic tumors on a 1.5 T MR-Linac: A global consensus protocol1
0.076781034469604